United States · FDA National Drug Code directory
Balsalazide Disodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-2575_ad2e8111-2fdf-88cd-521e-9a730f2f9bbb
- Product NDC
- 60505-2575
- Form
- CAPSULE
- Composition / generic term
- Balsalazide Disodium
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20071228
- Source listing expiry
- 20271231
Source-listed ingredients
- BALSALAZIDE DISODIUM — 750 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (60505-2575-0) / 10 CAPSULE in 1 BLISTER PACK · 60505-2575-0
- 30 CAPSULE in 1 BOTTLE (60505-2575-3) · 60505-2575-3
- 350 CAPSULE in 1 BOTTLE (60505-2575-4) · 60505-2575-4
- 280 CAPSULE in 1 BOTTLE (60505-2575-7) · 60505-2575-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →